These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 24835510)

  • 1. Size-exclusion chromatography-mass spectrometry with m-nitrobenzyl alcohol as post-column additive for direct characterization of size variants of monoclonal antibodies.
    Xu CF; Zang L; Weiskopf A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():230-8. PubMed ID: 24835510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of reduced monoclonal antibodies using size exclusion chromatography coupled with mass spectrometry.
    Liu H; Gaza-Bulseco G; Chumsae C
    J Am Soc Mass Spectrom; 2009 Dec; 20(12):2258-64. PubMed ID: 19786356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyphenation of size exclusion chromatography to native ion mobility mass spectrometry for the analytical characterization of therapeutic antibodies and related products.
    Ehkirch A; Hernandez-Alba O; Colas O; Beck A; Guillarme D; Cianférani S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1086():176-183. PubMed ID: 29684909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of monoclonal antibody fragments cleaved at the complementarity determining region using orthogonal analytical methods.
    Li W; Yang B; Zhou D; Xu J; Li W; Suen WC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1048():121-129. PubMed ID: 28242491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of 30 therapeutic antibodies and related products by size exclusion chromatography: Feasibility assessment for future mass spectrometry hyphenation.
    Goyon A; D'Atri V; Colas O; Fekete S; Beck A; Guillarme D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Oct; 1065-1066():35-43. PubMed ID: 28946123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-depth size and charge variants characterization of monoclonal antibody with native mass spectrometry.
    Dai J; Ji C
    Anal Chim Acta; 2023 Jul; 1265():341360. PubMed ID: 37230578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput multiplex analysis of mAb aggregates and charge variants by automated two-dimensional size exclusion-cation exchange chromatography coupled to mass spectrometry.
    Lambiase G; Inman SE; Muroni M; Lindo V; Dickman MJ; James DC
    J Chromatogr A; 2022 May; 1670():462944. PubMed ID: 35344792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of drug-product-related impurities and variants of a therapeutic monoclonal antibody by higher energy C-trap dissociation mass spectrometry.
    Wang D; Wynne C; Gu F; Becker C; Zhao J; Mueller HM; Li H; Shameem M; Liu YH
    Anal Chem; 2015 Jan; 87(2):914-21. PubMed ID: 25513708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of being metal-free: The critical choice of column hardware for size exclusion chromatography coupled to high resolution mass spectrometry.
    Murisier A; Fekete S; Guillarme D; D'Atri V
    Anal Chim Acta; 2021 Oct; 1183():338987. PubMed ID: 34627511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High resolution separation of recombinant monoclonal antibodies by size-exclusion ultra-high performance liquid chromatography (SE-UHPLC).
    Yang R; Tang Y; Zhang B; Lu X; Liu A; Zhang YT
    J Pharm Biomed Anal; 2015 May; 109():52-61. PubMed ID: 25766848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the mysteries of modern size exclusion chromatography - the way to achieve confident characterization of therapeutic proteins.
    Goyon A; Fekete S; Beck A; Veuthey JL; Guillarme D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1092():368-378. PubMed ID: 29936373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a novel modification to monoclonal antibodies: thioether cross-link of heavy and light chains.
    Tous GI; Wei Z; Feng J; Bilbulian S; Bowen S; Smith J; Strouse R; McGeehan P; Casas-Finet J; Schenerman MA
    Anal Chem; 2005 May; 77(9):2675-82. PubMed ID: 15859580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and characterization of antibody variants using mass spectrometry-based comparative analysis for biosimilar candidates of monoclonal antibody drugs.
    Li W; Yang B; Zhou D; Xu J; Ke Z; Suen WC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jul; 1025():57-67. PubMed ID: 27214604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-Column Denaturation-Assisted Native Size-Exclusion Chromatography-Mass Spectrometry for Rapid and In-Depth Characterization of High Molecular Weight Variants in Therapeutic Monoclonal Antibodies.
    Yan Y; Xing T; Liu AP; Zhang Z; Wang S; Li N
    J Am Soc Mass Spectrom; 2021 Dec; 32(12):2885-2894. PubMed ID: 34786946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of monoclonal antibody size variants containing extra light chains.
    Lu C; Liu D; Liu H; Motchnik P
    MAbs; 2013; 5(1):102-13. PubMed ID: 23255003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen exchange mass spectrometry reveals protein interfaces and distant dynamic coupling effects during the reversible self-association of an IgG1 monoclonal antibody.
    Arora J; Hickey JM; Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Weis DD; Volkin DB
    MAbs; 2015; 7(3):525-39. PubMed ID: 25875351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On-line coupling of size exclusion chromatography with mixed-mode liquid chromatography for comprehensive profiling of biopharmaceutical drug product.
    He Y; Friese OV; Schlittler MR; Wang Q; Yang X; Bass LA; Jones MT
    J Chromatogr A; 2012 Nov; 1262():122-9. PubMed ID: 22999205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid characterization of biotherapeutic proteins by size-exclusion chromatography coupled to native mass spectrometry.
    Haberger M; Leiss M; Heidenreich AK; Pester O; Hafenmair G; Hook M; Bonnington L; Wegele H; Haindl M; Reusch D; Bulau P
    MAbs; 2016; 8(2):331-9. PubMed ID: 26655595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the impact of antibody fragments on aggregation of intact molecules via size exclusion chromatography coupled with native mass spectrometry.
    Xu J; Coughlin JE; Szyjka M; Jabary S; Saluja S; Sosic Z; Chen Y; Xu CF
    MAbs; 2024; 16(1):2334783. PubMed ID: 38536719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On-line characterization of monoclonal antibody variants by liquid chromatography-mass spectrometry operating in a two-dimensional format.
    Alvarez M; Tremintin G; Wang J; Eng M; Kao YH; Jeong J; Ling VT; Borisov OV
    Anal Biochem; 2011 Dec; 419(1):17-25. PubMed ID: 21867674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.